clinical symptoms

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis

Understanding MOG Antibody-Associated Disease MOG antibody-associated disease (MOGAD) is increasingly recognized as a unique demyelinating condition in the pediatric population,

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis Read Post »

Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer’s Disease Neuroimaging Initiative study

Neuropsychological Criteria Overview The evaluation of Mild Cognitive Impairment (MCI) through neuropsychological criteria plays a crucial role in identifying individuals

Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer’s Disease Neuroimaging Initiative study Read Post »

Scroll to Top